early breast cancer

Explore academic connections and research related to this keyword

223
Views
8
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Highlights of the 16th St Gallen International Breast Cancer Conference, Vienna, Austria, 20-23 March 2019: personalised treatments for patients with early breast cancer.
Morigi, Consuelo;
2019 ecancermedicalscience DOI: 10.3332/ecancer.2019... 272 views
2
Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy - German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019).
Lüftner, Diana;Bauerfeind, Ingo;Braun, Michael;Brucker, Sara Y;Fasching, Peter A;Felberbaum, Ricardo...
2019 breast care (basel, switzerland) DOI: 10.1159/000502603 218 views
3
Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England.
Gannon, Melissa Ruth;Dodwell, David;Jauhari, Yasmin;Horgan, Kieran;Clements, Karen;Medina, Jibby;Cro...
2020 Journal of geriatric oncology DOI: S1879-4068(19)30494-... 278 views
4
Dose-Response Effects of Exercise on Glucose-Lowering Medications for Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
MacDonald, Christopher S;Johansen, Mette Y;Nielsen, Sabrina M;Christensen, Robin;Hansen, Katrine B;L...
2020 mayo clinic proceedings DOI: S0025-6196(19)30798-... 233 views

Related Journals

mayo clinic proceedings
ISSN: 1942-5546 631 views
Journal of geriatric oncology
ISSN: 1879-4076 564 views
ecancermedicalscience
ISSN: 1754-6605 437 views
breast care (basel, switzerland)
ISSN: 1661-3791 240 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

adjuvant consensus 16th st gallen consensus conference 2019 neoadjuvant therapies axilla locoregional therapy neoadjuvant treatment st. gallen consensus conference 2019 systemic therapy older women regional variation adjuvant trastuzumab her2-positive